Worldwide News

Scientists have found a new drug treatment that can slow the progression of neurodegenerative disease in mice. The breakthrough research may offer fresh hope in tackling currently untreatable conditions such as Alzheimer’s disease (AD).  The study was led by researchers at the University of Glasgow’s new Advanced Research Centre (ARC) and published in Science Signaling. […]

Join DDW for this free event Harnessing the power of IgE antibodies to create novel therapeutics. It will take place on December 13, 2022 at 5PM GMT and will be supported by SPT Labtech. From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: […]

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join the community.  The CoE aims to […]

Leica Microsystems and Cell Signaling Technology (CST) have agreed a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution.  As an open multiplexing system, Cell DIVE allows researchers to design custom antibody biomarker panels.  James O’Brien, Vice President Life Sciences at Leica Microsystems, said: “Instead of spending time validating antibodies, the pre-validated […]

The National Institute for Health and Care Excellence (NICE) has published a positive recommendation for Takeda’s EXKIVITY (mobocertinib) for treating EGFR Exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy within a Final Appraisal Document (FAD).1,2  In March 2022, Great Britain was the first country outside of the US to grant a conditional […]

Currently, no effective cure or treatment for Huntington’s disease exists. To accelerate Huntington’s disease research and drug discovery, researchers need access to physiologically relevant human disease models that recapitulate patient phenotypes, in combination with more advanced methods to understand the underlying mechanisms of the disease. Download this new App Note from bit.bio to learn: How […]

The Native Antigen Company (part of LGC Clinical Diagnostics) has launched its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.  The latest influenza antigens will help support development of vaccines and diagnostics as part of the ongoing vaccine reformulation programme, helping to ensure public safety throughout the annual flu season.  In […]

An Oxford University study has provided the first evidence that antibiotic resistant bacteria can travel from the gut to the lung, increasing the risk of deadly infections.  The findings coincide with World Antimicrobial Awareness Week and shed light on how antimicrobial resistance (AMR) arises and persists.   The study, which has been published in Nature Communications […]

Cancer Research UK’s innovation engine, Cancer Research Horizons, and Newcastle University, have agreed an extension of their strategic drug discovery alliance with Astex Pharmaceuticals.  The alliance will continue to focus on the discovery of potential new cancer drugs with associated biomarkers, with the aim of providing an innovative route to the development of more effective […]

Join DDW for this exclusive free event: Accessing Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies. The event will take place on 3PM GMT, 10AM EST and will be supported by Berkeley Lights. Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward […]